Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CPMDCANNAPHARMARX, INC.

OTC · CIK 0001081938
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts439

Identity from submissions API

NameCANNAPHARMARX, INC.
CIK0001081938
TickersCPMD
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN274635140
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone949-652-6838
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • GOLDEN DRAGON HOLDING CO. (2010-12-30T05:00:00.000Z → 2014-10-27T04:00:00.000Z)
  • CCVG, INC. (2011-01-12T05:00:00.000Z → 2011-01-12T05:00:00.000Z)
  • CONCORD VENTURES, INC. (2007-10-30T04:00:00.000Z → 2010-11-17T05:00:00.000Z)
  • CAVION TECHNOLOGIES INC (1999-07-29T04:00:00.000Z → 2007-07-25T04:00:00.000Z)
Business address
4439 TOWNSHIP RD 304
MOUNTAIN VIEW COUNTY
T0M 0R0
Alberta, Canada
A0
ALBERTA
Mailing address
4439 TOWNSHIP RD 304
MOUNTAIN VIEW COUNTY
T0M 0R0
Alberta, Canada
A0
ALBERTA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

367 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 10-Q FORM 10-Q FOR SEP 2026 0001683168-26-008887 000-27055 261564039 34 13335221 1 1
2026-11-17 NT 10-Q EXTENSION 0001683168-26-008879 000-27055 261563364 34 26976
2026-08-18 10-Q FORM 10-Q FOR JUN 2026 0001683168-26-006570 000-27055 261291624 34 5552541 1 1
2026-08-17 NT 10-Q NT 10-Q 0001683168-26-006523 000-27055 261286205 34 27177
2026-05-20 10-Q FORM 10-Q 0001654954-26-005180 000-27055 261003763 34 3545918 1 1
2026-05-18 NT 10-Q NT 10-Q 0001654954-26-005066 000-27055 26992115 34 30795
2026-03-31 10-K FORM 10-K 0001654954-26-003108 000-27055 26823682 34 7636801 1 1
2026-01-13 8-K FORM 8-K 5.02,8.01,9.01 0001654954-26-000277 000-27055 26528089 34 247708 1 1
2025-12-18 8-K FORM 8-K 8.01,9.01 0001654954-25-014070 000-27055 251580972 34 150796 1 1
2025-11-14 10-Q FORM 10-Q 0001654954-25-013083 000-27055 251486097 34 6349921 1 1
2025-10-10 8-K FORM 8-K 8.01,9.01 0001654954-25-011655 000-27055 251386954 34 1079918 1 1
2025-08-22 144 xsl144X01/primary_doc.xml 0002054793-25-000002 000-27055 251242424 33 4693
2025-08-14 10-Q FORM 10-Q 0001654954-25-009626 000-27055 251217879 34 5897588 1 1
2025-05-22 144 xsl144X01/primary_doc.xml 0002054793-25-000001 000-27055 25976531 33 4578
2025-05-16 10-Q FORM 10-Q 0001654954-25-005808 000-27055 25958439 34 6626082 1 1
2025-05-16 NT 10-Q NT 10-Q 0001654954-25-005804 000-27055 25958295 34 31810
2025-05-06 8-K FORM 8-K 8.01,9.01 0001654954-25-005135 000-27055 25916544 34 149473 1 1
2025-04-10 3 xslF345X02/ownership.xml 0001213900-25-030783 7488
2025-04-10 3 xslF345X02/ownership.xml 0001213900-25-030782 8246
2025-04-10 10-K FORM 10-K 0001654954-25-004122 000-27055 25828620 34 36008568 1 1
2025-04-01 NT 10-K NT 10-K 0001654954-25-003787 000-27055 25798500 34 21736
2025-03-31 8-K FORM 8-K 5.02 0001654954-25-003608 000-27055 25789103 34 154162 1 1
2024-12-03 8-K FORM 8-K 4.01,9.01 0001654954-24-015107 000-27055 241520426 34 152424 1 1
2024-11-21 8-K FORM 8-K 4.01,9.01 0001654954-24-014753 000-27055 241483454 34 173209 1 1
2024-11-14 10-Q FORM 10-Q 0001654954-24-014287 000-27055 241455940 34 5339115 1 1
2024-09-17 8-K CURRENT REPORT 5.02 0001683168-24-006456 000-27055 241302910 34 204490 1 1
2024-08-14 10-Q FORM 10-Q FOR JUNE 2024 0001683168-24-005699 000-27055 241208142 34 5090619 1 1
2024-06-25 10-Q FORM 10-Q FOR3/31/24 0001683168-24-004460 000-27055 241069307 34 4593857 1 1
2024-05-16 10-K FORM 10-K FOR DECEMBER 2023 0001683168-24-003575 000-27055 24955247 34 5589159 1 1
2024-05-15 NT 10-Q 10-Q EXTENSION 0001683168-24-003466 000-27055 24948132 34 25990
2024-03-27 NT 10-K EXTENSION 0001683168-24-001725 000-27055 24785407 34 26167
2024-02-22 8-K/A FORM 8-K AMENDMENT 9.01 0001683168-24-001108 000-27055 24662351 34 439742 1 1
2024-02-16 8-K CURRENT REPORT 1.01,9.01 0001683168-24-001042 000-27055 24646665 34 219735 1 1
2023-12-06 8-K FORM 8-K 1.01,2.01,3.02,9.01 0001683168-23-008658 000-27055 231469567 34 468960 1 1
2023-11-17 10-Q FORM 10-Q FOR SEPT 2023 0001683168-23-008281 000-27055 231418614 34 3905837 1 1
2023-11-14 NT 10-Q EXTENSION 0001683168-23-008104 000-27055 231404739 34 25247
2023-11-13 8-K FORM 8-K 4.01,9.01 0001683168-23-007964 000-27055 231397487 34 300211 1 1
2023-10-13 8-K CURRENT REPORT 5.02,9.01 0001683168-23-007145 000-27055 231324829 34 318353 1 1
2023-10-13 10-Q QUARTERLY REPORT 0001683168-23-007127 000-27055 231324128 34 3876105 1 1
2023-10-03 3 PRIMARY DOCUMENT 0001995107-23-000002 3097
2023-09-22 10-Q FORM 10-Q 0001683168-23-006631 000-27055 231271352 34 3593272 1 1
2023-09-01 10-K ANNUAL REPORT 0001683168-23-006237 000-27055 231231770 34 6958170 1 1
2023-08-28 8-K CURRENT REPORT 5.02,9.01 0001683168-23-006113 000-27055 231215898 34 225583 1 1
2023-06-23 8-K CURRENT REPORT 5.02,9.01 0001683168-23-004371 000-27055 231034810 34 216449 1 1
2023-03-30 NT 10-K EXTENSION 0001683168-23-001933 000-27055 23778054 34 26141
2022-11-21 10-Q FORM 10-Q 0001683168-22-007947 000-27055 221405798 34 4568199 1 1
2022-11-14 NT 10-Q REQUEST FOR EXTENSION 0001683168-22-007574 000-27055 221380162 34 25268
2022-10-04 DEF 14A DEF 14A 0001683168-22-006749 000-27055 221289213 34 126239
2022-08-26 PRE 14A PRE 14A 0001683168-22-006069 000-27055 221199297 34 128637
2022-08-22 10-Q FORM 10-Q 0001683168-22-005995 000-27055 221183856 34 4195403 1 1
2022-08-12 NT 10-Q EXTENSION 0001683168-22-005618 000-27055 221159360 34 25199
2022-08-11 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-08-11 09:00:00 9999999995-22-002348 333-266457 221157629 33 1992
2022-08-11 424B3 FORM 424(B)(3) 0001683168-22-005529 333-266457 221154047 33 321444
2022-08-09 S-1/A AMENDMENT NO. 1 TO S-1 0001683168-22-005456 333-266457 221147126 33 352880
2022-08-09 RW REQUEST FOR WITHDRAWAL 0001683168-22-005454 333-251016 221147100 NE 7889
2022-08-08 CORRESP filename1.htm 0001683168-22-005437 24855
2022-08-08 S-1/A AMENDMENT NO. 1 TO S-1 0001683168-22-005434 333-251016 221145274 33 352880
2022-08-08 UPLOAD filename1.pdf 0000000000-22-008387 40533
2022-08-01 S-1 FORM S-1 0001683168-22-005242 333-266457 221127069 33 455511
2022-05-23 10-Q FORM 10-Q 0001683168-22-003891 000-27055 22949601 34 3809836 1 1
2022-05-16 NT 10-Q EXTENSION 0001683168-22-003598 000-27055 22925460 34 25196
2022-04-15 10-K FORM 10-K 0001683168-22-002703 000-27055 22829234 34 4562508 1 1
2022-03-31 NT 10-K cannapharma_ext.htm 0001683168-22-002220 000-27055 22793205 34 25104
2022-02-16 8-K FORM 8-K 7.01,9.01 0001683168-22-001069 000-27055 22643497 34 206414 1 1
2021-11-15 10-Q FORM 10-Q 0001683168-21-005633 000-27055 211408048 34 4693078 1 1
2021-08-16 10-Q FORM 10-Q FOR JUNE 30, 2021 0001683168-21-003693 000-27055 211177218 34 4347309 1 1
2021-07-16 8-K FORM 8-K 1.01,7.01,9.01 0001683168-21-002989 000-27055 211095080 34 22854
2021-06-22 8-K FORM 8-K 1.01,7.01,9.01 0001683168-21-002671 000-27055 211035629 34 61657
2021-06-11 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-06-11 09:00:00 9999999995-21-002305 333-256123 211013199 33 1992
2021-06-10 424B3 FORM 424B3 0001683168-21-002450 333-256123 211007359 33 1009545
2021-06-09 CORRESP filename1.htm 0001683168-21-002433 20052
2021-06-09 8-K CURRENT REPORT 1.01,7.01,9.01 0001683168-21-002431 000-27055 211004408 34 337921
2021-05-26 CORRESP filename1.htm 0001683168-21-002247 18190
2021-05-26 S-1/A FORM S-1- AMENDMENT 1 0001683168-21-002246 333-256123 21967074 33 1196267
2021-05-24 UPLOAD filename1.pdf 0000000000-21-006512 43623
2021-05-17 10-Q FORM 10-Q 0001683168-21-002034 000-27055 21929481 34 3315517 1
2021-05-14 S-1 FORM S-1 0001683168-21-001989 333-256123 21923900 33 4044543 1
2021-05-04 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001683168-21-001709,2021-05-04 9999999995-21-001774 333-251016 21890975 33 2004
2021-05-03 POS AM POS AM 0001683168-21-001709 333-251016 21882030 33 1270265
2021-04-28 CORRESP filename1.htm 0001683168-21-001564 35593
2021-04-23 UPLOAD filename1.pdf 0000000000-21-005084 44682
2021-04-21 POS AM POS AM 2 0001683168-21-001486 333-251016 21842531 33 1366162
2021-04-21 CORRESP filename1.htm 0001683168-21-001485 36501
2021-04-20 UPLOAD filename1.pdf 0000000000-21-004884 45680
2021-04-15 POS AM POST EFFECTIVE AMENDMENT NO. 1 0001683168-21-001409 333-251016 21826854 33 1212564
2021-04-14 10-K ANNUAL REPORT 0001683168-21-001389 000-27055 21825677 34 3854173 1
2021-04-01 NT 10-K 10-K EXTENSION 0001683168-21-001176 000-27055 21796076 34 15890
2021-01-28 8-K FORM 8-K 1.01,7.01,9.01 0001683168-21-000300 000-27055 21566574 34 45578
2021-01-25 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-01-25 09:00:00 9999999995-21-000281 333-251016 21556605 33 1991
2021-01-22 8-K FORM 8-K 1.01,7.01,9.01 0001683168-21-000231 000-27055 21545728 34 87563
2021-01-20 424B3 PROSPECTUS 0001683168-21-000195 333-251016 21537994 33 1684473
2021-01-19 CORRESP filename1.htm 0001683168-21-000181 19451
2021-01-15 S-1/A FORM S-1 AMENDMENT 0001683168-21-000174 333-251016 21533098 33 1921922
2021-01-12 8-K FORM 8-K 1.01,7.01,9.01 0001683168-21-000119 000-27055 21523764 34 42563
2020-12-18 CORRESP filename1.htm 0001683168-20-004385 53825
2020-12-18 S-1/A FORM S-1 AMENDMENT 1 0001683168-20-004384 333-251016 201401483 33 1913574
2020-12-15 UPLOAD filename1.pdf 0000000000-20-011998 47075
2020-12-02 DEL AM DELAY REQUEST 0001683168-20-004138 333-251016 201363539 33 16255
2020-11-27 S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 0001683168-20-004117 333-251016 201357223 33 6069356 1
2020-11-12 10-Q FORM 10-Q 0001683168-20-003830 000-27055 201303500 34 3597537 1
2020-08-20 8-K FORM 8-K 1.01,2.03,7.01,9.01 0001683168-20-002827 000-27055 201119804 34 164232
2020-08-19 10-Q FORM 10-Q 0001683168-20-002818 000-27055 201117408 34 3461147 1
2020-08-14 NT 10-Q NOTICE OF LATE FILING 0001683168-20-002702 000-27055 201101748 34 16084
2020-07-06 8-K FORM 8-K 1.01,7.01,9.01 0001683168-20-002184 000-27055 201011838 34 285237
2020-06-29 10-Q QUARTERLY REPORT 0001683168-20-002112 000-27055 20996981 34 3171279 1
2020-06-29 DEF 14A DEFINITIVE PROXY 0001683168-20-002107 000-27055 20996451 34 158969
2020-06-26 4 xslF345X03/ownership.xml 0001683168-20-002077 5794
2020-06-22 10-K/A AMENDMENT NO. 1 0001683168-20-002022 000-27055 20978181 34 615096
2020-06-19 4 xslF345X03/ownership.xml 0001683168-20-002002 7898
2020-06-10 8-K FORM 8-K 1.01,7.01,9.01 0001683168-20-001924 000-27055 20954084 34 26114
2020-05-27 10-K ANNUAL REPORT 0001683168-20-001748 000-27055 20914597 34 3140299 1
2020-05-20 8-K FORM 8-K 7.01,9.01 0001683168-20-001687 000-27055 20896636 34 34030
2020-05-14 8-K CURRENT REPORT 8.01 0001683168-20-001538 000-27055 20875404 34 18300
2020-05-14 NT 10-K EXTENSION FOR 10-K 0001683168-20-001537 000-27055 20875396 34 15889
2020-04-29 3/A xslF345X02/primary_doc.xml 0001683168-20-001347 4393
2020-04-29 4 xslF345X03/ownership.xml 0001683168-20-001345 5286
2020-04-29 3/A xslF345X02/primary_doc.xml 0001683168-20-001343 4308
2020-04-29 3 xslF345X02/ownership.xml 0001683168-20-001306 3124
2020-03-27 8-K FORM 8-K 8.01 0001683168-20-000972 000-27055 20747343 34 20912
2020-03-17 8-K FORM 8-K 1.01,7.01,9.01 0001683168-20-000849 000-27055 20720819 34 102246
2020-02-10 8-K FORM 8-K 1.01,2.03,9.01 0001683168-20-000427 000-27055 20591383 34 346047
2020-02-07 8-K FORM 8-K 1.01,7.01,9.01 0001683168-20-000394 000-27055 20586889 34 72524
2020-02-04 3 xslF345X02/ownership.xml 0001683168-20-000363 4922
2020-02-04 3 xslF345X02/ownership.xml 0001683168-20-000343 4922
2020-02-03 4/A xslF345X03/ownership.xml 0001683168-20-000334 8223
2020-02-03 4 xslF345X03/ownership.xml 0001683168-20-000325 8144
2019-12-03 10-K/A FORM 10-K/A AMENDMENT 2 0001683168-19-003869 000-27055 191265689 34 51878
2019-11-20 10-Q/A FORM 10-Q AMENDMENT NO. 1 0001683168-19-003767 000-27055 191234346 34 508621
2019-11-20 10-Q/A FORM 10-Q AMENDMENT NO. 1 0001683168-19-003766 000-27055 191234251 34 393025
2019-11-14 10-Q FORM 10-Q 0001683168-19-003621 000-27055 191219507 34 2990655 1
2019-10-03 8-K FORM 8-K 1.01,7.01 0001683168-19-003144 000-27055 191133993 34 92804
2019-08-14 10-K/A FORM10-K AMENDMENT 0001683168-19-002603 000-27055 191024590 34 72103
2019-08-14 10-Q FORM 10-Q 0001683168-19-002602 000-27055 191024569 34 2639732 1
2019-06-26 3 PRIMARY DOCUMENT 0001128732-19-000015 3793
2019-06-26 3 PRIMARY DOCUMENT 0001128732-19-000014 3074
2019-06-12 8-K FORM 8-K 1.01,9.01 0001683168-19-001865 000-27055 19893171 34 505306
2019-05-15 10-Q FORM 10-Q 0001683168-19-001568 000-27055 19827133 34 2385327 1
2019-04-30 DEF 14A DEF 14A 0001683168-19-001253 000-27055 19781115 34 165806
2019-04-26 8-K CURRENT REPORT 5.02 0001683168-19-001205 000-27055 19770784 34 22919
2019-04-18 4 PRIMARY DOCUMENT 0001128732-19-000011 11400
2019-04-17 4 PRIMARY DOCUMENT 0001128732-19-000010 49760
2019-04-16 4/A PRIMARY DOCUMENT 0001128732-19-000009 14101
2019-04-03 10-K FORM 10-K 0001683168-19-000940 000-27055 19728683 34 2462940 1
2019-04-01 NT 10-K NOTICE OF LATE FILING 0001683168-19-000914 000-27055 19721821 34 28428
2019-03-13 D xslFormDX01/primary_doc.xml 06b 0001128732-19-000005 021-334705 19677301 33 8773
2019-03-12 3 PRIMARY DOCUMENT 0001128732-19-000004 4897
2019-03-01 8-K FORM 8-K 1.01,3.02,5.02,9.01 0001683168-19-000519 000-27055 19645936 34 31168
2019-02-14 8-K/A FORM 8-K AMENDMENT 1.01,3.02,5.06,7.01,9.01 0001683168-19-000383 000-27055 19605675 34 320560
2019-01-30 8-K FORM 8-K 3.02 0001683168-19-000224 000-27055 19552229 34 16792
2019-01-18 D/A xslFormDX01/primary_doc.xml 06b 0001128732-19-000001 021-319767 19532578 33 9049
2019-01-07 8-K/A FORM 8-K AMENDMENT 1.01,3.02,5.06,7.01,9.01 0001683168-19-000030 000-27055 19514118 34 320809
2018-12-18 DEF 14C DEFINITIVE INFORMATION STATEMENT 0001683168-18-003734 000-27055 181241050 34 58988
2018-12-06 PRE 14C FORM PRE14C 0001683168-18-003625 000-27055 181220141 34 65222
2018-11-21 8-K FORM 8-K 1.01,5.02,9.01 0001683168-18-003546 000-27055 181198853 34 454678
2018-11-13 10-Q QUARTERLY REPORT 0001683168-18-003366 000-27055 181177193 34 1155275 1
2018-09-20 3 PRIMARY DOCUMENT 0001128732-18-000015 4468
2018-09-14 10-Q FORM 10-Q FOR JUNE 30, 2018 0001683168-18-002749 000-27055 181070120 34 1001195 1
2018-09-14 10-Q FORM 10-Q FOR MARCH 31, 2018 0001683168-18-002746 000-27055 181070110 34 966984 1
2018-09-14 10-K FORM 10-K 0001683168-18-002744 000-27055 181070098 34 1227227 1
2018-09-14 10-Q FORM 10-Q 0001683168-18-002742 000-27055 181070090 34 1026552 1
2018-09-14 10-Q FORM 10-Q 0001683168-18-002740 000-27055 181070085 34 1028308 1
2018-09-14 10-Q QUARTERLY REPORT 0001683168-18-002738 000-27055 181070075 34 1004818 1
2018-09-14 10-K FORM 10-K 0001683168-18-002736 000-27055 181070065 34 1493377 1
2018-09-14 10-Q FORM 10-Q 0001683168-18-002734 000-27055 181070058 34 1260656 1
2018-09-14 10-Q FORM10-Q 0001683168-18-002732 000-27055 181070050 34 1253518 1
2018-09-14 10-Q FORM 10-Q 0001683168-18-002730 000-27055 181070046 34 1252790 1
2018-09-11 10-K FORM 10-K FOR 2015 0001683168-18-002697 000-27055 181063836 34 2085267 1
2018-08-22 D xslFormDX01/primary_doc.xml 06b 0001128732-18-000010 021-319767 181031532 33 8641
2018-06-15 8-K CURRENT REPORT 4.01,5.02,9.01 0001683168-18-001705 000-27055 18902012 34 69826
2018-04-13 8-K cannapharma8k4132018.htm 8.01 0001065949-18-000066 000-27055 18753689 34 12428
2016-06-02 8-K cannapharma8kjune12016.htm 5.02,9.01 0001065949-16-000412 000-27055 161690614 34 14990 1
2016-04-15 8-K cannapharma8kapr2016.htm 5.02,9.01 0001065949-16-000373 000-27055 161574911 34 24237 1
2016-03-30 NT 10-K nt10kcannapharmadec2015.htm 0001065949-16-000362 000-27055 161539330 34 31108
2016-01-13 8-K cannpharma8kjan2016.htm 5.02,9.01 0001065949-16-000323 000-27055 161339718 34 141283
2015-11-13 10-Q 10-Q 0001193125-15-376514 000-27055 151227073 34 2048910 1
2015-10-06 8-K/A LIVE FILING 5.07 0001299933-15-001462 000-27055 151146477 34 11121
2015-08-31 8-K LIVE FILING 5.07 0001299933-15-001298 000-27055 151084147 34 36500
2015-08-24 DEFA14A DEFA14A 0001193125-15-300042 000-27055 151070693 34 17013
2015-08-12 10-Q FORM 10-Q 0001193125-15-288206 000-27055 151047706 34 2230995 1
2015-08-10 D xslFormDX01/primary_doc.xml 06b 0001560208-15-000001 021-245385 151039858 33 14774
2015-08-07 D/A xslFormDX01/primary_doc.xml 06b 0001065949-15-000206 021-238003 151036092 33 14417
2015-07-21 3 PRIMARY DOCUMENT 0001065949-15-000188 5445
2015-07-21 SC 13D SC 13D - JAMES SMEEDING 0001193125-15-258033 005-58189 15997628 34 168698
2015-07-17 DEF 14A DEFINITIVE PROXY STATEMENT 0001193125-15-255086 000-27055 15992507 34 274372
2015-07-13 4 PRIMARY DOCUMENT 0001065949-15-000182 11125
2015-07-13 4 PRIMARY DOCUMENT 0001065949-15-000181 14008
2015-07-13 3 PRIMARY DOCUMENT 0001065949-15-000180 4113
2015-07-13 3 PRIMARY DOCUMENT 0001065949-15-000179 7135
2015-07-09 SC 13D SC13D - MATHEW SHERWOOD 0001193125-15-248998 005-58189 15981337 34 168767
2015-07-07 8-K LIVE FILING 8.01 0001299933-15-001055 000-27055 15976631 34 10795
2015-07-02 SC 13D SC 13D - GERRY CROCKER 0001193125-15-243735 005-58189 15967394 34 169686
2015-07-02 SC 13D SC 13D - GARY HERICK 0001193125-15-243732 005-58189 15967382 34 168517
2015-07-02 8-K LIVE FILING 3.02,5.01 0001299933-15-001026 000-27055 15966265 34 16522
2015-06-30 SC 13D/A cannapharmagroup13davfinal.txt 0001065949-15-000171 005-58189 15960452 34 132525
2015-06-30 SC 13D/A cannapharmagroup13davfinal.txt 0001065949-15-000170 005-58189 15960443 34 132538
2015-06-30 SC 13D/A cannapharmagroup13davfinal.txt 0001065949-15-000169 005-58189 15960421 34 132739
2015-06-30 4 PRIMARY DOCUMENT 0001065949-15-000168 5171
2015-05-28 8-K/A LIVE FILING 1.01,9.01 0001299933-15-000865 000-27055 15895244 34 117448
2015-05-27 8-K LIVE FILING 8.01 0001299933-15-000855 000-27055 15893021 34 10175
2015-05-14 10-Q FORM 10-Q 0001193125-15-187779 000-27055 15862298 34 2454300 1
2015-04-29 8-K LIVE FILING 3.02 0001299933-15-000662 000-27055 15812276 34 13031
2015-04-29 D/A xslFormDX01/primary_doc.xml 06b 0001209191-15-036940 021-238003 15811588 33 14341
2015-04-24 8-K LIVE FILING 1.01,3.02,5.01,9.01 0001299933-15-000634 000-27055 15792297 34 199471
2015-04-15 D xslFormDX01/primary_doc.xml 06b 0001209191-15-034172 021-238003 15770492 33 14224
2015-04-06 8-K LIVE FILING 5.02 0001299933-15-000518 000-27055 15753129 34 45643
2015-04-03 8-K FORM 8-K 1.01,3.02,9.01 0001193125-15-118668 000-27055 15750432 34 132195
2015-04-01 4 PRIMARY DOCUMENT 0001065949-15-000091 5516
2015-04-01 3 PRIMARY DOCUMENT 0001065949-15-000090 3056
2015-04-01 4 PRIMARY DOCUMENT 0001065949-15-000089 5525
2015-04-01 3 PRIMARY DOCUMENT 0001065949-15-000088 3070
2015-04-01 4 PRIMARY DOCUMENT 0001065949-15-000087 6276
2015-04-01 3 PRIMARY DOCUMENT 0001065949-15-000086 3818
2015-03-31 10-K 10-K 0001193125-15-113552 000-27055 15737676 34 2904646 1
2015-03-23 8-K cpmd8kmarch232015.txt 7.01,8.01,9.01 0001065949-15-000078 000-27055 15719462 34 12360
2015-03-05 4 PRIMARY DOCUMENT 0001065949-15-000068 5483
2015-03-05 3 PRIMARY DOCUMENT 0001065949-15-000067 3651
2015-03-05 4 PRIMARY DOCUMENT 0001065949-15-000066 5384
2015-03-05 3 PRIMARY DOCUMENT 0001065949-15-000065 2927
2015-03-03 8-K gdhc8knewdir.txt 5.02,7.01,9.01 0001072588-15-000035 000-27055 15666587 34 15506
2015-02-12 4 PRIMARY DOCUMENT 0001065949-15-000043 5697
2015-02-12 3 PRIMARY DOCUMENT 0001065949-15-000042 3248
2015-02-12 8-K cannapharma8kfeb92014.txt 5.02 0001065949-15-000041 000-27055 15606661 34 9304
2014-12-17 8-K gdhc8krd.txt 7.01,9.01 0001072588-14-000133 000-27055 141290797 34 10572
2014-12-12 8-K gdhc8kpressreleases.txt 7.01,9.01 0001072588-14-000131 000-27055 141282923 34 14608
2014-12-09 8-K gdhc8kshareholdermtg.txt 5.02,5.07 0001072588-14-000129 000-27055 141275432 34 5457
2014-11-21 DEF 14A cannapharmadef14anov2014.txt 0001065949-14-000296 000-27055 141243099 34 259745
2014-11-21 8-K canna8kcohen.txt 8.01 0001072588-14-000125 000-27055 141242327 34 5117
2014-11-19 10-Q cannapharma10qsept2014.txt 0001065949-14-000293 000-27055 141235425 34 1629020 1
2014-11-14 NT 10-Q nt10q09014.txt 0001072588-14-000114 000-27055 141222105 34 7426
2014-10-27 8-K gdhc8kcohensherwood.txt 5.02 0001072588-14-000108 000-27055 141174067 34 6084
2014-10-24 8-K gdhc8knamechange.txt 5.03,9.01 0001072588-14-000106 000-27055 141170758 34 7723
2014-10-09 DEF 14A gdhcdef14aoct2014.txt 0001065949-14-000249 000-27055 141149714 34 26934
2014-09-29 8-K gdhc8kcrocker.txt 5.02 0001072588-14-000098 000-27055 141126278 34 5271
2014-09-26 PRE 14A goldendragonpre14a.txt 0001065949-14-000237 000-27055 141124067 34 23006
2014-09-19 8-K gdhc8k.txt 3.02,5.02 0001072588-14-000095 000-27055 141111603 34 6728
2014-09-12 3 PRIMARY DOCUMENT 0001065949-14-000223 4578
2014-09-12 3 PRIMARY DOCUMENT 0001065949-14-000222 4556
2014-09-12 3 PRIMARY DOCUMENT 0001065949-14-000221 4536
2014-09-12 3 PRIMARY DOCUMENT 0001065949-14-000220 8683
2014-09-09 10-Q gdhc10q063014.txt 0001072588-14-000093 000-27055 141092799 34 1685587 1
2014-09-03 SC 13D cannapharmagroup13dvfinal.txt 0001065949-14-000211 005-58189 141078603 34 117566
2014-09-03 SC 13D cannapharmagroup13dvfinal.txt 0001065949-14-000210 005-58189 141078601 34 117575
2014-09-03 SC 13D cannapharmagroup13dvfinal.txt 0001065949-14-000209 005-58189 141078598 34 117579
2014-09-03 SC 13D cannapharmagroup13dvfinal.txt 0001065949-14-000208 005-58189 141078589 34 117780
2014-08-15 NT 10-Q nt10q063014.txt 0001072588-14-000081 000-27055 141044593 34 7427
2014-06-20 8-K gdhc8k3.02.txt 3.02 0001065949-14-000152 000-27055 14931546 34 5787
2014-06-04 D xslFormDX01/primary_doc.xml 06b 0001065949-14-000143 021-218525 14889312 33 9280
2014-06-04 8-K gdhc8kagrmerger.txt 1.01,3.02,5.02,9.01 0001065949-14-000142 000-27055 14889309 34 85045
2014-05-21 3 PRIMARY DOCUMENT 0001065949-14-000141 4392
2014-05-21 D xslFormDX01/primary_doc.xml 06b 0001065949-14-000140 021-217756 14860144 33 9490
2014-05-19 10-Q gdhc10q33114.txt 0001072588-14-000048 000-27055 14853894 34 1541621 1
2014-05-19 4 PRIMARY DOCUMENT 0001065949-14-000136 4729
2014-05-19 4 PRIMARY DOCUMENT 0001065949-14-000135 9036
2014-05-16 SC 14F1 goldendragon14fmay2014.txt 0001065949-14-000134 005-58189 14851062 34 27016
2014-05-16 8-K goldendragon8kmay92014.txt 3.02,5.01,5.02,8.01,9.01 0001065949-14-000133 000-27055 14849897 34 40178
2014-05-15 NT 10-Q nt10q033114.txt 0001072588-14-000045 000-27055 14848895 34 7442
2014-02-06 10-K gdhc10k123113.txt 0001072588-14-000014 000-27055 14578989 34 1627931 1
2014-02-03 UPLOAD filename1.pdf 0000000000-14-005432 39418
2014-01-31 8-K/A gdhc8kaauditor.txt 4.01,9.01 0001072588-14-000008 000-27055 14561892 34 9423
2014-01-30 CORRESP filename1.txt 0001072588-14-000012 4134
2014-01-30 CORRESP filename1.txt 0001072588-14-000010 2738
2014-01-29 UPLOAD filename1.pdf 0000000000-14-004604 156698
2014-01-27 8-K gdhc8kauditor.txt 4.01,9.01 0001072588-14-000006 000-27055 14547144 34 9128
2013-10-31 10-Q gdhc10q093013.txt 0001072588-13-000119 000-27055 131183420 34 1523216 1
2013-08-09 10-Q gdhc10q053113.txt 0001072588-13-000089 000-27055 131025048 34 2250081 1
2013-05-10 10-Q gdhc10q033113.txt 0001072588-13-000050 000-27055 13831895 34 1326322 1
2013-03-28 10-K goldendragon10k2012.txt 0001065949-13-000038 000-27055 13723467 34 1352997 1
2012-10-17 10-Q GDHC10Q93012.txt 0001072588-12-000150 000-27055 121148199 34 1264758 1
2012-07-25 10-Q goldendragon10qjune2012.txt 0001065949-12-000105 000-27055 12979418 34 1283364 1
2012-05-07 10-Q gdhc10q033112.txt 0001072588-12-000062 000-27055 12815439 34 971575 1
2012-03-14 10-K gdhc10k123111.txt 0001072588-12-000034 000-27055 12690003 34 1161115 1
2011-10-27 10-Q gdhc10q93011.txt 0001072588-11-000212 000-27055 111161468 34 812037 1
2011-07-25 10-Q gdhc10q063111.txt 0001072588-11-000141 000-27055 11983375 34 805659 1
2011-07-01 10-Q gdhc10q33111.txt 0001072588-11-000130 000-27055 11947133 34 786122 1
2011-06-30 10-K/A gdhc10ka123110.txt 0001072588-11-000120 000-27055 11941603 34 905817 1
2011-06-28 10-K gdhc10k123110.txt 0001072588-11-000113 000-27055 11933909 34 134248
2011-05-12 NT 10-Q gdhcnt10q33111.txt 0001072588-11-000092 000-27055 11833267 34 7463
2011-03-24 NT 10-K nt10k1210.txt 0001072588-11-000063 000-27055 11710182 34 7436
2011-02-16 UPLOAD filename1.pdf 0000000000-11-010117 46152
2011-02-10 CORRESP filename1.txt 0001072588-11-000022 2387
2011-01-28 8-K gdhc8kresaleofccaps.txt 1.01,2.01,3.02,9.01 0001072588-11-000014 000-27055 11553321 34 33085
2011-01-12 8-K/A ccvg8kaauditor.txt 4.01,9.01 0001072588-11-000009 000-27055 11524054 34 7452
2010-12-30 UPLOAD filename1.pdf 0000000000-10-078065 46623
2010-11-17 10-Q ccvg10q93010.txt 0001072588-10-000351 000-27055 101199203 34 67893
2010-11-17 8-K ccvg8kauditor.txt 9.01 0001072588-10-000347 000-27055 101199185 34 7335
2010-11-15 NT 10-Q nt10q910.txt 0001072588-10-000333 000-27055 101190722 34 7690
2010-10-14 8-K ccvg8kremerger.txt 1.01,5.03,9.01 0001072588-10-000284 000-27055 101123106 34 29622
2010-08-16 10-Q ccvr10q63010.txt 0001072588-10-000236 000-27055 101016448 34 69355
2010-05-14 10-Q ccvr10q310.txt 0001072588-10-000123 000-27055 10832300 34 67308
2010-05-04 UPLOAD filename1.pdf 0000000000-10-024306 40850
2010-04-15 10-K ccvg10k123110.txt 0001072588-10-000109 000-27055 10751668 34 135315
2010-04-14 CORRESP filename1.txt 0001072588-10-000106 4263
2010-03-22 UPLOAD filename1.pdf 0000000000-10-015691 50882
2010-03-19 NT 10-K nt10k1209.txt 0001072588-10-000072 000-27055 10692522 34 7686
2010-03-08 CORRESP filename1.txt 0001065949-10-000032 31023
2010-03-08 10-Q/A concord10qa.txt 0001065949-10-000031 000-27055 10663399 34 11830
2010-03-08 10-K/A concord10ka.txt 0001065949-10-000030 000-27055 10663398 34 15689
2010-02-22 UPLOAD filename1.pdf 0000000000-10-009930 53564
2010-01-20 10-Q/A ccvr10qa909.txt 0001072588-10-000014 000-27055 10534214 34 7236
2010-01-20 10-K/A ccvr10ka1208.txt 0001072588-10-000012 000-27055 10534187 34 14819
2010-01-19 CORRESP filename1.txt 0001072588-10-000016 18670
2009-12-10 UPLOAD filename1.pdf 0000000000-09-069787 60538
2009-11-16 10-Q ccvr10q909.txt 0001072588-09-000450 000-27055 091185690 34 72603
2009-08-10 10-Q ccvr10q609.txt 0001072588-09-000320 000-27055 09999015 34 90726
2009-05-13 10-Q ccvr10q309.txt 0001072588-09-000196 000-27055 09821520 34 85606
2009-03-31 10-K ccvr10k1208.txt 0001072588-09-000109 000-27055 09715412 34 161180
2009-01-22 8-K ccvr8kresignationofwes.txt 5.02 0001072588-09-000025 000-27055 09539144 34 10250
2008-11-13 10-Q ccvr10q908.txt 0001072588-08-000383 000-27055 081183505 34 99552
2008-10-06 PRE 14A ccvr14a92308.txt 0001072588-08-000343 000-27055 081107803 34 81241
2008-08-28 8-K ccvr8kunregsaleofsec.txt 3.02 0001072588-08-000306 000-27055 081043032 34 4597
2008-08-13 10-Q ccvr10q608.txt 0001072588-08-000254 000-27055 081012114 34 85088
2008-05-14 10-Q ccvr10q33108.txt 0001072588-08-000154 000-27055 08832261 34 77741
2008-05-05 8-K ccvr8kannualmtg.txt 8.01 0001072588-08-000139 000-27055 08801745 34 5742
2008-04-14 DEF 14A ccvrdef14a.txt 0001072588-08-000120 000-27055 08755027 34 190858
2008-03-19 PRE 14A ccvrpre14a.txt 0001072588-08-000078 000-27055 08697635 34 111818
2008-02-01 10KSB ccvr10k07.txt 0001072588-08-000041 000-27055 08567010 34 193112
2007-12-12 4 PRIMARY DOCUMENT 0001072588-07-000452 4933
2007-12-03 8-K dvi8kshareissuance.txt 3.02 0001072588-07-000446 000-27055 071281028 34 4290
2007-11-19 3 PRIMARY DOCUMENT 0001072588-07-000420 3894
2007-11-15 10QSB cvi10q93007.txt 0001072588-07-000419 000-27055 071249221 34 62437
2007-11-14 NT 10-Q nt10q907.txt 0001072588-07-000401 000-27055 071241659 34 7760
2007-10-30 3 PRIMARY DOCUMENT 0001072588-07-000375 3883
2007-10-30 3 PRIMARY DOCUMENT 0001072588-07-000374 4035
2007-07-25 10SB12G concordform10.txt 0001072588-07-000262 000-27055 07997805 34 307326
2001-03-05 15-12G c1512g.txt 0000895755-01-500028 000-27055 1560845 3355
2001-02-26 8-K c8k216.txt 3,5 0000895755-01-500026 000-27055 1553571 6789
2001-02-14 SC 13G/A c13gait.txt 0000895755-01-500022 005-58189 1545325 7989
2001-02-12 SC 13G/A c13gbc.txt 0000895755-01-500018 005-58189 1531834 8046
2001-02-09 SC 13G/A ca8kjfw1.txt 0000895755-01-500015 005-58189 1530228 8193
2001-02-06 SC 13G/A ca13gdjs.txt 0000895755-01-500008 005-58189 1526222 8089
2000-12-22 8-K 0001.txt 5 0000895755-00-000150 000-27055 795356 9458
2000-11-20 10QSB FORM 10-QSB 0000912057-00-050947 000-27055 773581 191247
2000-11-15 NT 10-Q 0001.txt 0000895755-00-000146 000-27055 770169 6029
2000-09-11 DEFS14A 0001.txt 0000895755-00-000123 000-27055 720330 35466
2000-09-07 PRES14A 0001.txt 0000895755-00-000119 000-27055 718469 35509
2000-08-25 PRES14A 0001.txt 0000895755-00-000115 000-27055 710501 30820
2000-08-11 10QSB FORM 10QSB 0000912057-00-036206 000-27055 692176 115690
2000-07-25 8-K 0001.txt 5 0000895755-00-000107 000-27055 678411 241386
2000-06-19 SC 13G/A 0001.txt 0000895755-00-000100 005-58189 657099 8448
2000-06-05 S-8 0001.txt 0000895755-00-000092 333-38548 648872 39695
2000-05-15 424B3 424B3 0000912057-00-024096 333-32270 630753 368913
2000-05-15 424B3 424B3 0000912057-00-024095 333-93929 630751 392461
2000-05-10 10QSB 10QSB 0000912057-00-023023 000-27055 625224 100931
2000-04-27 DEF 14A 0000895755-00-000076 0000895755-00-000076 000-27055 610804 76146
2000-04-14 S-1 S-1 0000912057-00-018202 333-34818 601976 749933
2000-03-16 SB-2/A 0000895755-00-000063 0000895755-00-000063 333-32270 571927 419062
2000-03-16 SC 13G 0000895755-00-000061 0000895755-00-000061 005-58189 571673 8231
2000-03-13 SB-2 0000895755-00-000055 0000895755-00-000055 333-32270 567161 421370
2000-03-08 10KSB40 0000895755-00-000051 0000895755-00-000051 000-27055 563104 252553
2000-02-14 SC 13G 0000895755-00-000030 0000895755-00-000030 005-58189 539409 7659
2000-02-14 SC 13G 0000895755-00-000027 0000895755-00-000027 005-58189 538663 8358
2000-02-14 SC 13G 0000895755-00-000026 0000895755-00-000026 005-58189 538559 8022
2000-02-14 SC 13G 0000895755-00-000025 0000895755-00-000025 005-58189 538529 8188
2000-02-08 DEFS14A 0000895755-00-000016 0000895755-00-000016 000-27055 526851 2688
2000-02-07 424B3 0000895755-00-000014 0000895755-00-000014 333-93929 525119 363462
2000-01-27 SB-2/A 0000895755-00-000010 0000895755-00-000010 333-93929 514990 435824
2000-01-05 SB-2/A 0000895755-00-000004 0000895755-00-000004 333-93929 501911 439888
1999-12-30 SB-2 0000895755-99-000108 0000895755-99-000108 333-93929 99784214 27244
1999-12-23 S-8 0000895755-99-000102 0000895755-99-000102 333-93579 99780254 15752
1999-12-13 10QSB 0000895755-99-000100 0000895755-99-000100 000-27055 99773595 237188
1999-11-04 424B3 0000895755-99-000092 0000895755-99-000092 333-80421 99740610 365688
1999-10-29 SB-2/A 0000895755-99-000086 0000895755-99-000086 333-80421 99736666 551825
1999-10-26 SB-2/A 0000895755-99-000080 0000895755-99-000080 333-80421 99733862 597030
1999-09-17 SB-2/A 0000895755-99-000067 0000895755-99-000067 333-80421 99713396 715250
1999-08-16 8-A12G 0000895755-99-000057 0000895755-99-000057 000-27055 99691461 67867
1999-07-29 SB-2/A 0000895755-99-000051 0000895755-99-000051 333-80421 99672331 632432
1999-06-10 SB-2 0000895755-99-000045 0000895755-99-000045 333-80421 99644418 1338618

Latest XBRL company facts

One latest value per concept from companyfacts (439 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 708.69M 2026-11-10 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
dei EntityPublicFloat Entity Public Float USD 2.58M 2025-06-30 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 6.12M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap AccountsPayableAndOtherAccruedLiabilities Accounts Payable and Other Accrued Liabilities USD 190,000 2024-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 3.12M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001683168-21-005633
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 10.69M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 174,830 2009-12-31 2010 FY 10-K/A 2011-06-30 0001072588-11-000120
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 7.21M 2023-03-31 2023 Q1 10-Q 2023-09-22 0001683168-23-006631
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 376,019 2021-03-31 2021 Q1 10-Q 2021-05-17 0001683168-21-002034
us-gaap AccountsPayableRelatedPartiesCurrentAndNoncurrent Accounts Payable, Related Parties USD 518,912 2021-03-31 2021 Q1 10-Q 2021-05-17 0001683168-21-002034
us-gaap AccountsReceivableGross Accounts Receivable, before Allowance for Credit Loss USD 185,616 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 164,430 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 4.40M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 190,000 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap AccruedRentCurrent Accrued Rent, Current USD 5.04M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 513,129 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 80,965 2025-03-31 2025 Q1 10-Q 2025-05-16 0001654954-25-005808
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 526,704 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 82.55M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 141,200 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap AdjustmentForAmortization Amortization USD 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-17 0001683168-21-002034
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2018-09-14 0001683168-18-002736
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 53,750 2022-07-01 2022-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 271,470 2023-01-01 2023-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 728,125 2016-01-01 2016-12-31 2018 FY 10-K 2019-04-03 0001683168-19-000940
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 4.08M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-12 0001193125-15-288206
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 45,245 2022-07-01 2022-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap AdvertisingExpense Advertising Expense USD 25,735 2015-01-01 2015-12-31 2015 FY 10-K 2018-09-11 0001683168-18-002697
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 4.82M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 162,392 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-06-25 0001683168-24-004460
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001683168-22-002703
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 629,416 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 48,750 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003621
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-13 0001683168-18-003366
us-gaap Assets Assets USD 7.29M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap AssetsCurrent Assets, Current USD 1.74M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap BankOverdrafts Bank Overdrafts USD 245 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap BusinessAcquisitionPercentageOfVotingInterestsAcquired Business Acquisition, Percentage of Voting Interests Acquired pure 1 2013-12-31 2013 FY 10-K 2014-02-06 0001072588-14-000014
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 1.93M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001683168-20-003830
us-gaap CapitalizedComputerSoftwareAdditions Capitalized Computer Software, Additions USD 50,000 2014-10-01 2014-12-31 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap CapitalizedComputerSoftwareAmortization Capitalized Computer Software, Amortization (Deprecated 2016-01-31) USD 0 2014-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 0 2014-12-31 2014 FY 10-K 2015-03-31 0001193125-15-113552
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 3,660 2009-12-31 2010 FY 10-K/A 2011-06-30 0001072588-11-000120
us-gaap Cash Cash USD 32,037 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2018-09-14 0001683168-18-002734
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 633 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 189,635 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001683168-20-003830
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 32,037 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 1,506 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 30,233 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 246,599 2020-09-30 2020 Q3 10-Q 2020-11-12 0001683168-20-003830
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD -209,788 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003621
us-gaap ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments USD 602,569 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001654954-25-013083
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.002 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 39.92M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap ClassOfWarrantOrRightUnissued Class of Warrant or Right, Unissued shares 0 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2021-09-30 2021 Q3 10-Q 2021-11-15 0001683168-21-005633
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 163.25M 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2025-12-31 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 5.00B 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 714.92M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 708.69M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap CommonStockSharesSubscribedButUnissued Common Stock, Shares Subscribed but Unissued shares 5.99M 2014-12-31 2014 FY 10-K 2015-03-31 0001193125-15-113552
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD 623 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap CommonStockValue Common Stock, Value, Issued USD 70,869 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -1.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 0 2021-12-31 2021 FY 10-K 2022-04-15 0001683168-22-002703
us-gaap ConversionGainsAndLossesOnForeignInvestments Conversion Gains and Losses on Foreign Investments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap ConvertibleDebt Convertible Debt USD 1.02M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 1.38M 2023-06-30 2023 Q2 10-Q 2023-10-13 0001683168-23-007127
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 1.02M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 1.02M 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 1.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 191,370 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001683168-22-002703
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 134,910 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 101.50M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-06-25 0001683168-24-004460
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 6.63M 2018-12-31 2019 Q3 10-Q 2019-11-14 0001683168-19-003621
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 227,386 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-23 0001683168-22-003891
us-gaap DebtInstrumentDecreaseForgiveness Debt Instrument, Decrease, Forgiveness USD -207,300 2009-01-01 2009-12-31 2010 FY 10-K/A 2011-06-30 0001072588-11-000120
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 513,110 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 488,117 2019-12-31 2019 FY 10-K 2020-05-27 0001683168-20-001748
us-gaap DebtInstrumentUnamortizedDiscountCurrent Debt Instrument, Unamortized Discount, Current USD 0 2023-06-30 2023 Q2 10-Q 2023-10-13 0001683168-23-007127
us-gaap DeferredCostsAndOtherAssets Deferred Costs and Other Assets USD 0 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 1.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD 1.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap DeferredIncomeRevenueRecognized DeferredIncomeRevenueRecognized USD 231,608 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001654954-25-009626
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 3.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 25,000 2015-03-31 2015 Q1 10-Q 2015-05-14 0001193125-15-187779
us-gaap DeferredRevenue Deferred Revenue USD 36,298 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 36,298 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 861,476 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 206,910 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD -4,546 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 1.64M 2014-12-31 2014 FY 10-K 2015-03-31 0001193125-15-113552
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 28.28M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 26.25M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 596,000 2014-12-31 2014 FY 10-K 2015-03-31 0001193125-15-113552
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 91,000 2014-12-31 2014 FY 10-K 2015-03-31 0001193125-15-113552
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.45M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 231,000 2014-12-31 2014 FY 10-K 2015-03-31 0001193125-15-113552
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements USD 718,000 2014-12-31 2014 FY 10-K 2015-03-31 0001193125-15-113552
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 1.64M 2014-12-31 2014 FY 10-K 2015-03-31 0001193125-15-113552
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 7,540 2024-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap DepositAssets Deposit Assets USD 0 2021-09-30 2021 Q3 10-Q 2021-11-15 0001683168-21-005633
us-gaap DepositLiabilitiesAccruedInterest Deposit Liabilities, Accrued Interest USD 1.72M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap Deposits Deposits USD 15,757 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 80,680 2021-06-30 2021 Q2 10-Q 2021-08-16 0001683168-21-003693
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 0 2015-12-31 2016 Q1 10-Q 2018-09-14 0001683168-18-002730
us-gaap Depreciation Depreciation USD 87,278 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001654954-24-014287
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 15,808 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 53,726 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap DepreciationExpenseOnReclassifiedAssets Depreciation Expense on Reclassified Assets USD 41,866 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 929,977 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap DerivativeLiabilities Derivative Liability USD 1.75M 2020-09-30 2020 Q3 10-Q 2020-11-12 0001683168-20-003830
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 1.08M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 317,772 2014-03-31 2014 Q1 10-Q 2014-05-19 0001072588-14-000048
us-gaap DueFromRelatedParties Due from Related Parties USD 76,699 2018-09-30 2018 Q3 10-Q 2018-11-13 0001683168-18-003366
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 213,934 2013-12-31 2014 Q3 10-Q 2014-11-19 0001065949-14-000293
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.02 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001683168-21-005633
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.3 2015-01-01 2015-12-31 2015 FY 10-K 2018-09-11 0001683168-18-002697
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.245 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.411 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001193125-15-113552
us-gaap EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent pure -0.39 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-06 0001072588-14-000014
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.004 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001193125-15-113552
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.018 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001193125-15-113552
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.058 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001193125-15-113552
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 259,857 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001683168-21-005633
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -455 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 212,383 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-10-13 0001683168-23-007127
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 7.97M 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 50,000 2026-02-01 2026-02-03 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD -690,712 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 721,451 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 497,582 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001654954-25-009626
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 5.48M 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 17.51M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 12.04M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive Finance Lease, Liability, Payments, Due in Rolling after Year Five USD 999,733 2023-06-30 2023 Q2 10-Q 2023-10-13 0001683168-23-007127
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 1.09M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 979,012 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 1.09M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 1.09M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 1.09M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.09M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 11.48M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 758,738 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 4.93M 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap FinanceLeaseRightOfUseAssetAccumulatedAmortization Finance Lease, Right-of-Use Asset, Accumulated Amortization USD 473,142 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 41,866 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization Finance Lease, Right-of-Use Asset, before Accumulated Amortization USD 5.41M 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.169 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap FinancingInterestExpense Financing Interest Expense USD 311,542 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2020-12-31 2020 FY 10-K 2021-04-14 0001683168-21-001389
us-gaap ForeignCurrencyExchangeRateTranslation1 Foreign Currency Exchange Rate, Translation pure 0.717 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap ForeignCurrencyTransactionGainBeforeTax Foreign Currency Transaction Gain, before Tax USD 66,252 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -77,448 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap ForeignCurrencyTransactionGainLossUnrealizedAfterTax ForeignCurrencyTransactionGainLossUnrealizedAfterTax USD -77,448 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax USD 31,084 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 6,755 2021-09-30 2021 Q3 10-Q 2021-11-15 0001683168-21-005633
us-gaap GainLossOnCondemnation Gain (Loss) on Condemnation USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2018-09-14 0001683168-18-002736
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2018-09-14 0001683168-18-002736
us-gaap GainOrLossOnSaleOfStockInSubsidiary Gain (Loss) on Disposition of Stock in Subsidiary USD 676,989 2010-01-01 2010-12-31 2011 FY 10-K 2012-03-14 0001072588-12-000034
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 410,537 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap Goodwill Goodwill USD 0 2021-03-31 2021 Q1 10-Q 2021-05-17 0001683168-21-002034
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001683168-22-002703
us-gaap GrossProfit Gross Profit USD -693,142 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap ImpairmentOfInvestments Other than Temporary Impairment Losses, Investments USD 4.52M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 450,456 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-14 0001654954-25-009626
us-gaap IncentiveFeePayable IncentiveFeePayable USD 305,492 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -1.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -317,772 2011-01-01 2014-03-31 2014 Q1 10-Q 2014-05-19 0001072588-14-000048
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001654954-25-013083
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 4,254 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 3.52M 2015-01-01 2015-12-31 2015 FY 10-K 2018-09-11 0001683168-18-002697
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -2.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 1.01M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -199,754 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap IncomeTaxReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount USD 125 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap IncomeTaxReconciliationTaxSettlements Effective Income Tax Rate Reconciliation, Tax Settlement, Amount USD 79,356 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -52,206 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001065949-14-000293
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 2.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001683168-21-005633
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 157,368 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 630,632 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -25,894 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001065949-14-000293
us-gaap IncreaseDecreaseInBookOverdrafts Increase (Decrease) in Book Overdrafts USD 0 2017-01-01 2017-06-30 2017 Q2 10-Q 2018-09-14 0001683168-18-002740
us-gaap IncreaseDecreaseInDeferredCompensation Increase (Decrease) in Deferred Compensation USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2018-09-11 0001683168-18-002697
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -223,141 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2018-09-14 0001683168-18-002734
us-gaap IncreaseDecreaseInDueToOfficersAndStockholders Increase (Decrease) in Due to Officers and Stockholders USD 60,000 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-14 0001072588-12-000034
us-gaap IncreaseDecreaseInIncomeTaxes Increase (Decrease) in Income Taxes USD -3.52M 2015-01-01 2015-12-31 2015 FY 10-K 2018-09-11 0001683168-18-002697
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD -25,102 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 1.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap IncreaseDecreaseInMortgageLoansHeldForSale Increase (Decrease) in Mortgage Loans Held-for-sale USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-06-29 0001683168-20-002112
us-gaap IncreaseDecreaseInNotesPayableCurrent Increase (Decrease) in Notes Payable, Current USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001683168-21-003693
us-gaap IncreaseDecreaseInNotesPayableRelatedParties Increase (Decrease) in Notes Payable, Related Parties USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-23 0001683168-22-003891
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-09-22 0001683168-23-006631
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 703,456 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 5.73M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-23 0001683168-22-003891
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2018-09-14 0001683168-18-002736
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 7,113 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD -68,906 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-10-13 0001683168-23-007127
us-gaap IncreaseDecreaseInRoyaltiesPayable Increase (Decrease) in Royalties Payable USD 224,316 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap IntangibleAssetsCurrent Intangible Assets, Current USD 0 2021-03-31 2021 Q1 10-Q 2021-05-17 0001683168-21-002034
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 0 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 930,347 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001654954-25-009626
us-gaap InterestExpense Interest Expense USD 1.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap InterestExpenseDebt Interest Expense, Debt USD 616,024 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap InterestExpenseInterestBearingLiability InterestExpenseInterestBearingLiability USD 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 1.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap InterestExpenseOther Interest Expense, Other USD 879,362 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 8,533 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-10-17 0001072588-12-000150
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -2,071 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap InterestIncomeOther Interest Income, Other USD 0 2015-01-01 2015-12-31 2016 FY 10-K 2018-09-14 0001683168-18-002736
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 2,071 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap InterestPayableCurrent Interest Payable, Current USD 2.65M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 2.15M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 1.10M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap InventoryFinishedGoodsAndWorkInProcessNetOfReserves Inventory, Finished Goods and Work in Process, Net of Reserves USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 946,045 2026-06-30 2026 Q2 10-Q 2026-08-18 0001683168-26-006570
us-gaap InventoryGross Inventory, Gross USD 64,684 2024-03-31 2024 Q1 10-Q 2024-06-25 0001683168-24-004460
us-gaap InventoryNet Inventory, Net USD 1.70M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 599,624 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 1.05M 2026-06-30 2026 Q2 10-Q 2026-08-18 0001683168-26-006570
us-gaap InventoryWriteDown Inventory Write-down USD 864,567 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap InvestmentIncomeNet Investment Income, Net USD -1,553 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-12 0001193125-15-288206
us-gaap Investments Investments USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 142,800 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 987,973 2015-01-01 2015-12-31 2015 FY 10-K 2018-09-11 0001683168-18-002697
us-gaap Land Land USD 0 2020-12-31 2020 FY 10-K 2021-04-14 0001683168-21-001389
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 1.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap LeaseCost Lease, Cost USD 1.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap LegalFees Legal Fees USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 495,000 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.20M 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.15M 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.09M 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.04M 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap Liabilities Liabilities USD 37.47M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 7.29M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap LiabilitiesCurrent Liabilities, Current USD 32.67M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap LiabilitiesSubjectToCompromiseDebtAndAccruedInterest Liabilities Subject to Compromise, Debt and Accrued Interest USD 1.04M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2024-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap LitigationReserveCurrent Estimated Litigation Liability, Current USD 190,000 2024-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap LitigationReserveNoncurrent Estimated Litigation Liability, Noncurrent USD 0 2015-12-31 2015 FY 10-K 2018-09-11 0001683168-18-002697
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 50,000 2015-01-01 2015-12-31 2015 FY 10-K 2018-09-11 0001683168-18-002697
us-gaap LoansPayable Loans Payable USD 14.38M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap LongTermDebt Long-term Debt USD 7.00M 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003621
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 1.00M 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003621
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 335,144 2026-06-30 2026 Q2 10-Q 2026-08-18 0001683168-26-006570
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-04-14 0001683168-21-001389
us-gaap MarketingAndAdvertisingExpense Marketing and Advertising Expense USD 103,766 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001065949-14-000293
us-gaap MortgageLoansOnRealEstatePeriodIncreaseDecrease SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Period Increase (Decrease) USD 9,945 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-15 0001683168-19-001568
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 624,069 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 805,865 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -55,706 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -2,078 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -537,675 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -2.21M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -1.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD -1.67M 2021-04-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001683168-21-003693
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -467,435 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001683168-21-003693
us-gaap NetInvestmentInLeaseAfterAllowanceForCreditLoss NetInvestmentInLeaseAfterAllowanceForCreditLoss USD 21,186 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -51,530 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap NotesAndLoansPayable Notes and Loans Payable USD 8.79M 2019-12-31 2019 FY 10-K 2020-05-27 0001683168-20-001748
us-gaap NotesIssued1 Notes Issued USD 6.63M 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-03 0001683168-19-000940
us-gaap NotesPayable Notes Payable USD 478,604 2025-09-30 2025 Q3 10-Q 2025-11-14 0001654954-25-013083
us-gaap NotesPayableCurrent Notes Payable, Current USD 423,738 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 94,471 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap NotesPayableRelatedPartiesCurrentAndNoncurrent Notes Payable, Related Parties USD 94,471 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap NotesPayableToBankCurrent Notes Payable to Bank, Current USD 0 2019-12-31 2019 FY 10-K 2020-05-27 0001683168-20-001748
us-gaap NumberOfOperatingSegments Number of Operating Segments Integer 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap NumberOfReportableSegments Number of Reportable Segments Integer 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap OperatingExpenses Operating Expenses USD 900,975 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -1.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 812,204 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 5.85M 2022-03-31 2022 Q1 10-Q 2022-05-23 0001683168-22-003891
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 966,490 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 4.81M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.07M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 5.35M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 18,540 2017-09-30 2017 Q3 10-Q 2018-09-14 0001683168-18-002742
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 26,419 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 14,364 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001683168-22-002703
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.169 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 96.00M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 94,406 2013-12-31 2013 FY 10-K 2014-02-06 0001072588-14-000014
us-gaap OtherAccountsPayableAndAccruedLiabilities Other Accounts Payable and Accrued Liabilities USD 5.42M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 50,000 2015-12-31 2016 Q1 10-Q 2018-09-14 0001683168-18-002730
us-gaap OtherAssetsCurrent Other Assets, Current USD 0 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 583,375 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap OtherComprehensiveIncomeLossBeforeTax Other Comprehensive Income (Loss), before Tax USD -11.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -945 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap OtherDepreciationAndAmortization Other Depreciation and Amortization USD 1,946 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001683168-21-005633
us-gaap OtherExpenses Other Expenses USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap OtherIncome Other Income USD 402,394 2022-01-01 2022-12-31 2022 FY 10-K 2023-09-01 0001683168-23-006237
us-gaap OtherLiabilities Other Liabilities USD 13.31M 2020-06-30 2020 Q2 10-Q 2020-08-19 0001683168-20-002818
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 908,462 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap OtherLoansPayable Other Loans Payable USD 13.12M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap OtherNoncashExpense Other Noncash Expense USD 0 2015-01-01 2015-12-31 2016 FY 10-K 2018-09-14 0001683168-18-002736
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 300,322 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap OtherNotesPayable Other Notes Payable USD 48,580 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap OtherNotesPayableCurrent Other Notes Payable, Current USD 7.63M 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 167,199 2021-09-30 2021 Q3 10-Q 2021-11-15 0001683168-21-005633
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 54,318 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 879,362 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap PaymentsForConstructionInProcess Payments for Construction in Process USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-14 0001683168-21-001389
us-gaap PaymentsForDeposits Payments for Deposits USD 76,699 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-13 0001683168-18-003366
us-gaap PaymentsForDepositsOnRealEstateAcquisitions Payments for Deposits on Real Estate Acquisitions USD 50,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001193125-15-113552
us-gaap PaymentsForOtherDeposits Payments for Other Deposits USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003621
us-gaap PaymentsForOtherOperatingActivities Payments for Other Operating Activities USD 243,656 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap PaymentsForProceedsFromOtherDeposits Payments for (Proceeds from) Other Deposits USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2018-09-14 0001683168-18-002736
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 350,000 2015-03-01 2015-03-30 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2018-09-14 0001683168-18-002734
us-gaap PaymentsToAcquireBusinessesAndInterestInAffiliates Payments to Acquire Businesses and Interest in Affiliates USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-09-01 0001683168-23-006237
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-05-27 0001683168-20-001748
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-17 0001683168-21-002034
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 52,800 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap PaymentsToAcquireOtherPropertyPlantAndEquipment Payments to Acquire Other Property, Plant, and Equipment USD 74,700 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-10-13 0001683168-23-007127
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 55,706 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap PreferredStockNoParValue Preferred Stock, No Par Value USD/shares 1 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2024-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 3.20M 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 60,000 2018-12-31 2019 Q2 10-Q 2019-08-14 0001683168-19-002602
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 629,416 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 455,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001654954-24-014287
us-gaap PreferredUnitsOutstanding Preferred Units, Outstanding shares 629,416 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 7,106 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 71,746 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap PrepaidInterest Prepaid Interest USD 29,610 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003621
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap ProceedsFromDerivativeInstrumentFinancingActivities Proceeds from Derivative Instrument, Financing Activities USD 2.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries Proceeds from Divestiture of Interest in Consolidated Subsidiaries USD 100 2010-01-01 2010-12-31 2010 FY 10-K/A 2011-06-30 0001072588-11-000120
us-gaap ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates Proceeds from Divestiture of Interest in Subsidiaries and Affiliates USD 100 2010-01-01 2010-12-31 2011 FY 10-K 2012-03-14 0001072588-12-000034
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan Proceeds from Issuance of Common Stock, Dividend Reinvestment Plan USD 249,991 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 11,973 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-14 0001683168-21-001389
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 363,448 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 804,500 2015-09-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001654954-25-013083
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 242,485 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD 0 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-10-13 0001683168-23-007127
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 624,069 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap ProceedsFromRepaymentsOfShortTermDebt Proceeds from (Repayments of) Short-term Debt USD -3,566 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001683168-20-003830
us-gaap ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001683168-21-005633
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2018-09-14 0001683168-18-002736
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-14 0001683168-21-001389
us-gaap ProfessionalFees Professional Fees USD 265,820 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -382,021 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 211,042 2025-03-31 2025 Q1 10-Q 2025-05-16 0001654954-25-005808
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 194,651 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap PropertyPlantAndEquipmentOther Property, Plant and Equipment, Other, Gross USD 2,766 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003621
us-gaap PropertyPlantAndEquipmentOtherNet Property, Plant and Equipment, Other, Net USD 6,032 2021-12-31 2021 FY 10-K 2022-04-15 0001683168-22-002703
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 9,679 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 4.11M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001654954-25-009626
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 600 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-28 0001065949-13-000038
us-gaap RelatedPartyTransactionRate Related Party Transaction, Rate pure 0.08 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-19 0001072588-14-000048
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001654954-25-013083
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 255,001 2021-01-01 2021-12-31 2022 FY 10-K 2023-09-01 0001683168-23-006237
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 468,383 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -113.96M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap Revenues Revenues USD 1.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 5.78M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-18 0001683168-26-006570
us-gaap RoyaltyExpense Royalty Expense USD 224,618 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap SaleLeasebackTransactionImputedInterestRate Sale Leaseback Transaction, Imputed Interest Rate pure 0.169 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 116,640 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap ServicingLiability Servicing Liability USD 0 2024-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001654954-24-014287
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 1.72M 2015-04-01 2015-06-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date pure 0.5 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-19 0001072588-14-000048
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 0.003 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 3.524 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.03 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 75,000 2014-03-31 2014 Q1 10-Q 2014-05-19 0001072588-14-000048
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 750,000 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 6.08M 2014-11-02 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 0 2024-09-30 2024 Q3 10-Q 2024-11-14 0001654954-24-014287
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 1.37 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 2.62 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 1 2014-11-02 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit USD/shares 3.25 2014-11-02 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap SharePrice Share Price USD/shares 0.004 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap ShortTermInvestments Short-term Investments USD 221,714 2019-03-31 2019 Q1 10-Q 2019-05-15 0001683168-19-001568
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 45,245 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-17 0001683168-23-008281
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -30.19M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 100 2010-12-31 2010 FY 10-K/A 2011-06-30 0001072588-11-000120
us-gaap StockholdersEquityNoteStockSplitConversionRatio Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) pure 3 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-10 0001072588-13-000050
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 3 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001193125-15-113552
us-gaap StockIssued1 Stock Issued USD 1.61M 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-03 0001683168-19-000940
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 2.00M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 0 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-19 0001072588-14-000048
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 9.00M 2014-05-09 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 5.63M 2014-11-02 2015-06-30 2015 Q2 10-Q 2015-08-12 0001193125-15-288206
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 55,989 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 866,701 2023-01-01 2023-12-31 2024 FY 10-K 2025-04-10 0001654954-25-004122
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 0 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 142,800 2025-10-01 2025-12-31 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 75,471 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 5.17M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 10,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001683168-22-002703
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 2.25M 2015-03-01 2015-03-30 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 98,955 2019-01-01 2019-12-31 2020 FY 10-K 2021-04-14 0001683168-21-001389
us-gaap TradingLiabilities Trading Liabilities USD 5.91M 2026-03-31 2026 Q1 10-Q 2026-05-20 0001654954-26-005180
us-gaap TravelAndEntertainmentExpense Travel and Entertainment Expense USD 10,886 2022-01-01 2022-12-31 2022 FY 10-K 2023-09-01 0001683168-23-006237
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 6.23M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 623 2025-03-31 2025 Q1 10-Q 2025-05-16 0001654954-25-005808
us-gaap TreasuryStockShares Treasury Stock, Shares shares 133,200 2022-09-30 2022 Q3 10-Q 2022-11-21 0001683168-22-007947
us-gaap TreasuryStockValue Treasury Stock, Value USD 13 2023-06-30 2023 Q2 10-Q 2023-10-13 0001683168-23-007127
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003621
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued Unrecognized Tax Benefits, Income Tax Penalties Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 1.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001654954-26-003108
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 687.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 17.84M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-376514
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 687.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001683168-26-008887

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →